Today: 9 June 2026
CoreWeave stock edges higher after insider-sale filings; what CRWV investors are watching next
30 December 2025
1 min read

CoreWeave stock edges higher after insider-sale filings; what CRWV investors are watching next

NEW YORK, December 30, 2025, 12:16 ET — Regular session

  • CoreWeave shares rose about 0.5% in midday trading.
  • A Form 4 filing showed Chief Strategy Officer Brian Venturo sold 281,250 shares via an affiliated entity under a 10b5-1 plan.
  • Traders are looking ahead to the next earnings update expected in early February, according to Zacks.

CoreWeave (CRWV) shares inched higher on Tuesday after late Monday regulatory filings disclosed stock sales tied to a senior executive and director.

The disclosures matter because CoreWeave remains a high-volume, high-volatility AI infrastructure name, and investors have been closely tracking insider selling and financing as the company scales data center capacity.

Insider trades can sway sentiment in companies like CoreWeave that require heavy upfront spending, especially after the firm warned earlier this quarter that a third-party data center delay would pressure its outlook.

The Nasdaq-listed shares were up about 0.5% at $75.27 by 12:16 p.m. ET, after trading between $74.01 and $75.83.

A Form 4 filing showed Chief Strategy Officer and director Brian Venturo reported sales of 281,250 Class A shares on Dec. 24 through West Clay Capital LLC, an entity the filing said he controls. The shares were sold in multiple transactions at prices ranging from $78.57 to $80.93 and were executed under a Rule 10b5-1 trading plan adopted on May 21, 2025, the filing showed.

A separate Form 144 notice listed the same 281,250-share sale with an aggregate market value of about $22.6 million and named Morgan Stanley Smith Barney as the broker. “Sales that were executed on December 24, 2025 are being reported on this Form 144 filed on December 29, 2025,” Venturo wrote in the filing. StreetInsider.com

Form 4 is the SEC filing corporate insiders use to report stock transactions. Form 144 is a notice filed under SEC Rule 144, which governs sales of restricted or “control” securities; it is often used to signal an insider’s intent to sell shares. A 10b5-1 plan is a pre-set trading instruction that schedules trades in advance.

AI-linked stocks were mixed on the day, with Nvidia little changed and Core Scientific down about 1%.

CoreWeave rents out computing capacity built around Nvidia chips to AI customers. In November, it cut its annual revenue forecast after a delay at a third-party data center partner and said 2025 capital spending would be $12 billion to $14 billion.

The company has also tapped capital markets to fund buildout, pricing an upsized $2.25 billion convertible senior notes offering earlier this month, it said.

Investors are now watching for any further insider filings, data center capacity updates and changes to demand signals from large customers.

The next quarterly report is expected in early February; Zacks lists Feb. 9 as the next expected earnings date.

Stock Market Today

  • Visa Expands Payment Network via Valor PayTech Partnership
    June 9, 2026, 2:14 PM EDT. Visa Inc. has enhanced its payment infrastructure by fully certifying Valor PayTech's terminal ecosystem with its Visa Platform Connect (VPC). This collaboration allows merchants and fintechs using Valor PayTech technology to access Visa's global payment network through a streamlined integration, supporting in-store, mobile, and unattended transactions. The partnership aligns with Visa's strategy to embed payment capabilities deeper into commerce, offering tools like digital wallet acceptance, tokenization, and real-time processing. Visa processed 135.5 billion transactions in H1 fiscal 2026, up 9% year-on-year. Competitors Mastercard and PayPal pursue similar expansions via fintech partnerships and platform strategies. Visa shares have declined 13.7% over the past year but trade at a forward P/E of 22.39, above the industry average of 15.83, reflecting market confidence in its growth potential.

Latest articles

Bitcoin Hovers at $61,000 With CPI Report in Focus for Crypto Traders

Bitcoin Hovers at $61,000 With CPI Report in Focus for Crypto Traders

9 June 2026
Bitcoin slid to near $61,000, down 3%, as traders cut risk ahead of Wednesday’s U.S. inflation report, which is expected to show May CPI up 4.2% year-on-year—well above the Fed’s 2% target—keeping rate-hike risk in play and pressuring crypto and related stocks, with $5.8 billion in digital asset outflows reported in recent weeks.
AHMA Shares Jump Over 100% With Little News Out

AHMA Shares Jump Over 100% With Little News Out

9 June 2026
Ambitions Enterprise Management Co. L.L.C shares soared 185% to $3.08 on Nasdaq with over 60 million shares traded, despite no new company news since April 30; the surge outpaced travel peers and left the price below its $4 IPO, with the company warning in its annual report of potential volatility, competition, seasonal risks, and a $5 million capital need.
Rigetti Drops 14% With Quantum Names Hit in Tech Selloff

Rigetti Drops 14% With Quantum Names Hit in Tech Selloff

9 June 2026
Rigetti shares plunged 14.4% to $18.64, erasing gains from bullish Bernstein commentary, as investors dumped high-growth tech stocks sector-wide despite analyst optimism on quantum computing’s future; the drop followed a director’s proposed stock sale and comes as Rigetti awaits finalization of a potential $100 million federal award.
Archer Aviation Drops After Cathie Wood Selloff; What Traders Are Tracking

Archer Aviation Drops After Cathie Wood Selloff; What Traders Are Tracking

9 June 2026
Archer Aviation plunged 9.1% to $5.21 after ARK Invest dumped over 2.2 million shares worth $12.7 million, intensifying pressure as investors fled speculative growth stocks; with FAA certification still pending and heavy cash burn, Archer’s stock remains vulnerable to further selloffs if milestones slip.
SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next
Previous Story

SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target
Next Story

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target

Go toTop